Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temperature-mediated plasticity of floral and fitness traits in <i>Arabidopsis thaliana</i>.

Quantitative plant biology·2026
Same author

Spliceosomal Factor SmF Modulates Temperature-Mediated Flower and Leaf Size Plasticity in Arabidopsis thaliana.

Plant, cell & environment·2026
Same author

Chronic cluster headache is a rare disease: Implications for diagnosis, treatment and public health.

Cephalalgia : an international journal of headache·2025
Same author

A dual role of fibroblast-epithelial crosstalk in acute and chronic lung injury.

The Journal of biological chemistry·2025
Same author

Amylin and the amylin receptors in migraine: Is there another pathway to target?

Cephalalgia : an international journal of headache·2025
Same author

Evidence-based guidelines for the pharmacological treatment of migraine.

Cephalalgia : an international journal of headache·2025
Same journal

An overview of the safety and efficacy of sphenopalatine ganglion stimulation for the treatment of chronic cluster headache.

Expert review of neurotherapeutics·2026
Same journal

Multiomics and proteomic insights into Alzheimer's disease biology in Down syndrome.

Expert review of neurotherapeutics·2026
Same journal

Remote deep brain stimulation programming in childhood dystonia: opportunities, challenges, and future directions.

Expert review of neurotherapeutics·2026
Same journal

The differential diagnosis of astrocytic neoplasms and its impact on treatment and prognosis.

Expert review of neurotherapeutics·2026
Same journal

Corticosteroids in withdrawal therapy following medication-overuse headache: a systematic review.

Expert review of neurotherapeutics·2026
Same journal

Clinical efficacy of lacosamide in neuropathic pain: a systematic review of randomized controlled trials.

Expert review of neurotherapeutics·2026
See all related articles

Related Experiment Video

Updated: May 29, 2026

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache
05:40

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache

Published on: July 29, 2021

Recent advances in headache research.

Jan Hoffmann1

  • 1Headache Group, Department of Neurology, University of California San Francisco, San Francisco, CA 94143-0114, USA. jan.hoffmann@ucsf.edu

Expert Review of Neurotherapeutics
|September 30, 2011
PubMed
Summary
This summary is machine-generated.

Migraine is now understood as a brain disorder, not a vascular issue. New insights into its complex mechanisms and brain structures are paving the way for innovative migraine treatments.

More Related Videos

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

Investigating Migraine-Like Behavior Using Light Aversion in Mice
05:23

Investigating Migraine-Like Behavior Using Light Aversion in Mice

Published on: August 11, 2021

Related Experiment Videos

Last Updated: May 29, 2026

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache
05:40

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache

Published on: July 29, 2021

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

Investigating Migraine-Like Behavior Using Light Aversion in Mice
05:23

Investigating Migraine-Like Behavior Using Light Aversion in Mice

Published on: August 11, 2021

Area of Science:

  • Neurology
  • Neuroscience
  • Headache Medicine

Background:

  • Over the past 20 years, understanding of primary headache disorders, particularly migraine, has significantly advanced.
  • Migraine is now primarily viewed as a central nervous system disorder, challenging older vascular or meningeal theories.

Purpose of the Study:

  • To highlight recent scientific advances in migraine pathophysiology presented at the American Headache Society Annual Meeting.
  • To discuss the clinical implications of these new findings for therapeutic development.

Main Methods:

  • Review of presentations and discussions from the American Headache Society Annual Meeting.
  • Synthesis of current research on migraine pathophysiology and brain structures involved.

Main Results:

  • Substantial improvement in understanding migraine pathophysiology.
  • Consensus shifting towards migraine as a primary brain disorder.
  • Identification of complex pathophysiological mechanisms and involved brain structures.

Conclusions:

  • Advances in understanding migraine pathophysiology are crucial for developing novel therapeutic strategies.
  • The focus on brain mechanisms opens new avenues for effective migraine treatment.
  • Continued research and discussion at scientific meetings are vital for clinical progress.